Krystal Biotech, Inc.
Mid Cap · Healthcare · Biotechnology
$332.88−$2.85 (-0.85%)
Krystal Biotech, Inc.
Mid Cap · Healthcare · Biotechnology
$332.88−$2.85 (-0.85%)
Stock analysis
Get the AI take on KRYS
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$130.50
High$382.54
Today $332.88
RSI (14)
47.6Neutral
03070100
Overall score
68/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$284
Current price
$332.88
Median target
$386
Highest
$474
LowHigh
Operating Record
Revenue
What's working
- Cash exceeds debt by $1.1B, leaving a net cash buffer, a good sign.
- ROIC: Money put back into the business keeps coming back out as profit, a hallmark of a durable moat.
What to watch
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
- Price / sales: Revenue alone can't justify this price; profits need to catch up fast.
What the market charges
Forward P/E
Needs attention · 115% above avg
39.35x
Price / sales
Rich · Priced well above what its revenue alone supports
22.33x
Price / FCF
Rich · Priced far above what its cash flow currently supports
38.15x
EV / EBITDA
Rich · Operating earnings don't yet support this price
43.86x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
40.2%
ROE
Favorable · 19.9% - strong capital efficiency
20.1%
Debt / equity
Favorable · 0.01 - strong leverage
0.01x
Current ratio
Strong · Comfortable room to cover bills due within a year
8.32x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $9.83B | 41.6 | +22.6% | 68 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |